BC
TSVT

Bartlett & Co’s 2seventy bio TSVT Stock Holding History

Bartlett & Co’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$0 Hold
33
– – ﹤0.01% 1248
2023
Q3 		$0 Hold
33
– – ﹤0.01% 1180
2023
Q2 		$0 Hold
33
– – ﹤0.01% 1163
2023
Q1 		$0 Hold
33
– – ﹤0.01% 1095
2022
Q4 		$0 Hold
33
– – ﹤0.01% 1176
2022
Q3 		$0 Hold
33
– – ﹤0.01% 1267
2022
Q2 		$0 Hold
33
– – ﹤0.01% 1309
2022
Q1 		$1K Buy
+33
New +$560 ﹤0.01% 1037

Other funds holding TSVT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Bartlett & Co's TSVT Position: Q4 2023 in Review

Bartlett & Co held its 2seventy bio (TSVT) position steady in Q4 2023 at 33 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1248.

Bartlett & Co first reported a position in TSVT in Q1 2022 and has held it in 8 quarters since. The position peaked at $1K in Q1 2022. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • Bartlett & Co held 33 shares of 2seventy bio worth $0 as of Q4 2023.
  • Bartlett & Co left its 2seventy bio share count unchanged in Q4 2023.
  • 2seventy bio made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #1248 holding.
  • Bartlett & Co first reported a position in 2seventy bio in Q1 2022 and has held it in 8 quarters since.
  • Bartlett & Co's 2seventy bio position peaked at $1K in Q1 2022.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.